Literature DB >> 18804409

End of life considerations in the head and neck cancer patient.

James J Sciubba1.   

Abstract

Oral and head and neck cancer carries an associated death rate five years after diagnosis and treatment that is high, essentially at a 50% level. In association with the dying process and the transition to death is a wide array of issues and considerations including the physical and emotional needs of the patient as well as associated caregivers. At a point, the transition must be understood in terms of non-oncologic management considerations and the broader needs of the patient and their family and the caregivers. Psychosocial and spiritual needs are to be addressed as well as the necessary components of preparation for death as to make a "good death". Communicating the status of the terminally-ill patient to the patient themselves and their family when cure or remission is no longer possible and the consideration of hospice care, palliation and issues of grieving all contribute to considerations in overall management at the end of life.

Entities:  

Mesh:

Year:  2008        PMID: 18804409     DOI: 10.1016/j.oraloncology.2008.06.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer.

Authors:  Carolyn L Mulvey; Thomas J Smith; Christine G Gourin
Journal:  Head Neck       Date:  2015-06-16       Impact factor: 3.147

2.  End-of-life care for head and neck cancer patients: a population-based study.

Authors:  Tzu-Lung Kuo; Ching-Heng Lin; Rong-San Jiang; Ting-Ting Yen; Chen-Chi Wang; Kai-Li Liang
Journal:  Support Care Cancer       Date:  2016-12-30       Impact factor: 3.603

3.  Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.

Authors:  Benjamin H Lok; Ginger Jiang; Stanley Gutiontov; Ryan M Lanning; Sudeepta Sridhara; Eric J Sherman; Chiaojung Jillian Tsai; Sean M McBride; Nadeem Riaz; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-08-14       Impact factor: 5.337

4.  A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Authors:  Nadeem Riaz; Julian C Hong; Eric J Sherman; Luc Morris; Matthew Fury; Ian Ganly; Tony J C Wang; Weji Shi; Suzanne L Wolden; Andrew Jackson; Richard J Wong; Zhigang Zhang; Shyam D Rao; Nancy Y Lee
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

5.  Palliative Head and Neck Cancer Treatment for Asymptomatic Disease.

Authors:  Divya Yerramilli; Kevin J Kovatch; Annie W Chan; Paul Swiecicki; Danielle N Margalit; Andrew G Shuman
Journal:  Otolaryngol Head Neck Surg       Date:  2018-02-27       Impact factor: 3.497

6.  Psychological management for head and neck cancer patients: United Kingdom National Multidisciplinary Guidelines.

Authors:  G Humphris
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

7.  National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database.

Authors:  Zachary G Schwam; Barbara Burtness; Wendell G Yarbrough; Saral Mehra; Zain Husain; Benjamin L Judson
Journal:  Cancer Med       Date:  2015-10-16       Impact factor: 4.452

8.  A qualitative examination of patient priorities and preferences during treatment decision-making for recurrent head and neck cancer.

Authors:  Bethany A Rhoten; Jessie I Sellers; Breanna Baraff; Kelly H Holler; Sheila H Ridner
Journal:  Support Care Cancer       Date:  2020-05-06       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.